Shearman & Sterling advised Caris Life Sciences in the transaction. The financing includes a $235 million equity investment co-led by Highland Capital Management and Coatue, with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
